Pliant Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Pliant Therapeutics

09/08/2023 21:52

* Pliant Therapeutics Inc  PLRX.OQ  reported a quarterly
adjusted
loss of 70 cents​​ per share for the quarter ended in June. The
mean expectation of thirteen analysts for the quarter was for a
loss of 71 cents per share.
    * Revenue fell 95% to $248.00 thousand from a year ago;
analysts
expected $881.82 thousand. 
    * Pliant Therapeutics Inc's reported EPS for the quarter was
a
loss of 70 cents​.
    * The mean earnings estimate of analysts had risen by
about 1.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Pliant Therapeutics Inc shares had risen by 0.3% this
quarter and lost 6.0% so far this year.
    * The company reported a quarterly loss of $41.19 million.
    * Wall Street's median 12-month price target for Pliant
Therapeutics Inc is $48.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 14 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 08:51 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.71          -0.70          Beat
 Mar. 31 2023      -0.67          -0.67          Met
 Dec. 31 2022      -0.70          -0.72          Missed
 Sep. 30 2022      -0.74          -0.65          Beat